Residual Stenosis and Restenosis Following Carotid Endarterectomy With Primary Closure, A Prospective Tracking Study

Recruiting Observational Study
Carotid Arteriosclerosis Carotid Stenosis Brain Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Observational
Participants needed
300 (estimated)
Sponsor
Charles University, Czech Republic · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This prospective, multicenter observational study aims to evaluate the incidence, timing, and characteristics of residual and recurrent (restenosis) carotid artery stenosis following carotid endarterectomy (CEA) with primary closure. Conducted across several neurosurgical centers in the Czech Republic, the study will include patients undergoing elective CEA who meet standard clinical indications. …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: Patients without matching any of exclusion criteria who underwent cartotid endarterectomy Exclusion Criteria: Age ≤18 or ≥90 years Previous endarterectomy or stenting Unsuitable vascular anatomy High perioperative risk Contralateral cranial nerve X or XII palsy History of…
Contacts

norbert Svoboda, MD

+420973202963

norbert.svoboda@uvn.cz

CONTACT